CD81 and Sepsis: In conclusion, we report that CD14+/CD81+ BAL EV are enriched in patients with sepsis-related ARDS compared with controls, and that an elevated CD14+/CD81+ BAL EV count is associated with increased mortality in patients with ARDS, although the sample size is modest.